Genetic modifiers of Friedreich's ataxia pathophysiology in Drosophila melanogaster - A systematic review and meta-analysis.

What was studied

This review pooled studies done in Drosophila models of Friedreich's ataxia. The disease is caused by low levels of frataxin protein. The review compared gene changes that alter signs of the disease. Study quality was checked with a standard tool. The review also graded each change by how well it worked.

What they found

Gene changes improved survival, eye signals, movement and enzyme activity in the models. Brain vacuolization also improved. Results varied widely between studies for all signs. More ferritin, blocked Miro and more catalase ranked highest. These act on iron balance, cell energy parts and stress from oxygen.

What it means for patients

The authors suggest these changes as targets for more study. They call for better reporting in future work.

Why it is not certain yet

These results come from Drosophila models, not from people. Results varied widely between studies. The authors call for common reporting rules and shared raw data. They also call for checks across several signs of disease. The abstract does not say how many studies were pooled.

Source

Genetic modifiers of Friedreich's ataxia pathophysiology in Drosophila melanogaster - A systematic review and meta-analysis.

We restate facts from the source record in our own words. The original wording belongs to its publisher.